Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

100.80p
   
  • Change Today:
      0.40p
  • 52 Week High: 110.00
  • 52 Week Low: 75.00
  • Currency: UK Pounds
  • Shares Issued: 538.04m
  • Volume: 76,686
  • Market Cap: £542.35m
  • RiskGrade: 119
  • Beta: 0.21

Latest ShareCast News

Alliance Pharma trades strongly in first half

By Josh White

Date: Tuesday 21 Sep 2021

(Sharecast News) - Healthcare company Alliance Pharma reported strong trading in its first half on Tuesday, reporting a 24% rise in see-through revenue to £80.9m.

Alliance Pharma trades strongly through first half

By Josh White

Date: Tuesday 20 Jul 2021

(Sharecast News) - Healthcare company Alliance Pharma updated the market on its first half on Tuesday, reporting that it had traded "strongly", with see-through revenue rising 24% year-on-year to £80.9m, or 28% on a constant currency basis.

Strong trading continues in new year for Alliance Pharma

By Josh White

Date: Wednesday 19 May 2021

(Sharecast News) - Alliance Pharma updated the market on its trading on Wednesday, reiterating that the year had started well, adding that it was continuing to see some "strong performances" from its key brands.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 100.80p
Change Today 0.40p
% Change 0.40 %
52 Week High 110.00
52 Week Low 75.00
Volume 76,686
Shares Issued 538.04m
Market Cap £542.35m
Beta 0.21
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.52% below the market average85.52% below the market average85.52% below the market average85.52% below the market average85.52% below the market average
22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average
Price Trend
58.03% above the market average58.03% above the market average58.03% above the market average58.03% above the market average58.03% above the market average
26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average
Income
48.38% below the market average48.38% below the market average48.38% below the market average48.38% below the market average48.38% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Growth
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 03-Dec-2021

Time Volume / Share Price
10:42 473 @ 100.80p
10:42 266 @ 100.80p
10:41 1,538 @ 101.00p
10:41 943 @ 100.80p
10:40 139 @ 100.80p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page